4.2 Review

Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challenges

Related references

Note: Only part of the references are listed.
Review Chemistry, Multidisciplinary

Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges

Weisen Zhang et al.

Summary: Polymeric nanoparticles have shown great potential in overcoming the blood-brain barrier for effective drug delivery, with their unique properties offering high tunability and ease of synthesis. Careful analysis of their performance in transporting drugs across the blood-brain barrier is essential for successful drug delivery to the central nervous system.

ADVANCED SCIENCE (2021)

Review Chemistry, Medicinal

Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways

Amanda Cano et al.

Summary: Epilepsy is a chronic disease of the central nervous system characterized by an electrical imbalance in neurons. The molecular processes that trigger epileptic seizures and promote neurotoxic effects are currently focused on the glutamate pathway and influx of calcium ions into neurons. Common molecular links between epilepsy and other neurodegenerative diseases have led to investigation of antiseizure drugs for therapeutic potential in these pathologies.

PHARMACEUTICALS (2021)

Review Biotechnology & Applied Microbiology

Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer's disease: from current to future challenges

Amanda Cano et al.

Summary: Increasing life expectancy has led to a rise in dementia cases, particularly Alzheimer's disease, which is expected to reach 131 million cases by 2050. The lack of effective treatments and late diagnosis hinder disease management, highlighting the urgent need for improved diagnostic tools and therapeutic approaches for AD. Nanomedicine-based technologies, including advanced nanoparticles, show promise in improving drug effectiveness and tracking disease progression.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Article Pharmacology & Pharmacy

Preparation, physicochemical and biopharmaceutical characterization of oxcarbazepine-loaded nanostructured lipid carriers as potential antiepileptic devices

S. Scioli Montoto et al.

Summary: The study demonstrated that encapsulating oxcarbazepine in nanostructured lipid carriers (NLCs) results in high drug encapsulation efficiency and a release mechanism driven by non-Fickian molecular release. In vitro permeability studies showed enhanced permeability of the encapsulated drug compared to free oxcarbazepine.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2021)

Review Clinical Neurology

Action of antiepileptic drugs on neurons

Katsuhiro Kobayashi et al.

BRAIN & DEVELOPMENT (2020)

Review Chemistry, Multidisciplinary

Systemic Review of Biodegradable Nanomaterials in Nanomedicine

Shi Su et al.

NANOMATERIALS (2020)

Review Nanoscience & Nanotechnology

Key for crossing the BBB with nanoparticles: the rational design

Sonia M. Lombardo et al.

BEILSTEIN JOURNAL OF NANOTECHNOLOGY (2020)

Review Biochemistry & Molecular Biology

Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology

Aleksandra Zielinska et al.

MOLECULES (2020)

Review Neurosciences

Epilepsy surgery for refractory seizures: a systematic review and meta-analysis in different complications

Maryam Joudi Mashhad et al.

EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY (2020)

Review Medicine, General & Internal

Epilepsy in adults

Roland D. Thijs et al.

LANCET (2019)

Review Engineering, Biomedical

Biocompatible Polymer Nanoparticles for Drug Delivery Applications in Cancer and Neurodegenerative Disorder Therapies

Eleonora Calzoni et al.

JOURNAL OF FUNCTIONAL BIOMATERIALS (2019)

Article Engineering, Environmental

Bioengineered PLGA-chitosan nanoparticles for brain targeted intranasal delivery of antiepileptic TRH analogues

Sarabjit Kaur et al.

CHEMICAL ENGINEERING JOURNAL (2018)

Article Biochemistry & Molecular Biology

Piperine-loaded chitosan-STPP nanoparticles reduce neuronal loss and astrocytes activation in chemical kindling model of epilepsy

Diana Anissian et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)

Article Pharmacology & Pharmacy

Nanoparticle-based delivery of carbamazepine: A promising approach for the treatment of refractory epilepsy

Anna Zybina et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)

Review Medicine, General & Internal

The management of epilepsy in children and adults

Piero Perucca et al.

MEDICAL JOURNAL OF AUSTRALIA (2018)

Article Nanoscience & Nanotechnology

Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: A new anti-seizure strategy for temporal lobe epilepsy

Amanda Cano et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)

Review Medicine, Research & Experimental

Current Strategies for Brain Drug Delivery

Xiaowei Dong

THERANOSTICS (2018)

Review Biotechnology & Applied Microbiology

Nano based drug delivery systems: recent developments and future prospects

Jayanta Kumar Patra et al.

JOURNAL OF NANOBIOTECHNOLOGY (2018)

Article Pharmacology & Pharmacy

Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents

Teresa Musumeci et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)

Article Clinical Neurology

ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology

Ingrid E. Scheffer et al.

ZEITSCHRIFT FUR EPILEPTOLOGIE (2018)

Article Pharmacology & Pharmacy

Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part I - Barriers and determining factors in ocular delivery

E. Sanchez-Lopez et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)

Article Pharmacology & Pharmacy

Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part II - Ocular drug-loaded lipid nanoparticles

E. Sanchez-Lopez et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)

Review Clinical Neurology

Drug-Resistant epilepsy: Multiple Hypotheses, Few Answers

Fei Tang et al.

FRONTIERS IN NEUROLOGY (2017)

Review Toxicology

The Pharmacology and Toxicology of Third-Generation Anticonvulsant Drugs

Paul LaPenna et al.

JOURNAL OF MEDICAL TOXICOLOGY (2017)

Review Pharmacology & Pharmacy

Breaking Bad: the Structure and Function of the Blood-Brain Barrier in Epilepsy

Hadas Han et al.

AAPS JOURNAL (2017)

Article Multidisciplinary Sciences

Glucose is a key driver for GLUT1-mediated nanoparticles internalization in breast cancer cells

Leonardo Venturelli et al.

SCIENTIFIC REPORTS (2016)

Article Biochemistry & Molecular Biology

A Synopsis of Nano-Technological Approaches Toward Anti-Epilepsy Therapy: Present and Future Research Implications

Nasimudeen R. Jabir et al.

CURRENT DRUG METABOLISM (2015)

Article Biochemistry & Molecular Biology

Formulation and evaluation of chitosan solid lipid nanoparticles of carbamazepine

Rahul Nair et al.

LIPIDS IN HEALTH AND DISEASE (2012)

Article Instruments & Instrumentation

SLN approach for nose-to-brain delivery of alprazolam

Alok Pratap Singh et al.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2012)

Review Biophysics

Biodegradable polymeric nanoparticles based drug delivery systems

Avnesh Kumari et al.

COLLOIDS AND SURFACES B-BIOINTERFACES (2010)

Review Pharmacology & Pharmacy

Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles

Christian Wischke et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)

Review Clinical Neurology

The blood-brain barrier and epilepsy

Emily Oby et al.

EPILEPSIA (2006)

Review Chemistry, Multidisciplinary

Biodegradable polymeric nanoparticles as drug delivery devices

KS Soppimath et al.

JOURNAL OF CONTROLLED RELEASE (2001)